• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by HWH International Inc.

    2/11/26 7:37:45 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care
    Get the next $HWH alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001261725
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    HWH INTERNATIONAL INC.
    SEC File Number
    001-41254
    Address of Issuer
    4800 MONTGOMERY LANE, SUITE 210,
    BETHESDA
    MARYLAND
    20814
    Phone
    301-971-3955
    Name of Person for Whose Account the Securities are To Be Sold
    Chan Heng Fai Ambrose; Alset Inc.; Alset International Limited
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Chairman and Chief Executive Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock, $0.0001 Par Value
    UBS AG Hong Kong Branch
    2 International Finance Centre
    52/F, 8 Finance Street
    Central, � K3 � 00000
    300465459711.45747640002/12/2026
    Nasdaq Stock Market


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Stock, $0.0001 Par Value01/09/2024880,000 shares acquired by Alset International Limited as merger consideration on 01/09/2024;IssuerCheckbox not checked88000001/09/2024Merger consideration relating to the Issuer's business combination which occurred on January 9, 2024

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Date of Notice
    02/11/2026

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Chan Heng Fai Ambrose

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $HWH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HWH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HWH
    SEC Filings

    View All

    SEC Form 144 filed by HWH International Inc.

    144 - HWH International Inc. (0001897245) (Subject)

    2/11/26 7:37:45 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    HWH International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - HWH International Inc. (0001897245) (Filer)

    2/5/26 8:45:59 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by HWH International Inc.

    SCHEDULE 13D/A - HWH International Inc. (0001897245) (Subject)

    12/1/25 5:17:55 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HWH International Inc. Announces Reverse Stock Split

    BETHESDA, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced a 1-for-5 reverse stock split of the Company's common stock to become effective at 9:00 a.m. (Eastern Time) on February 24, 2025. The Company's common stock is expected to begin trading on a split-adjusted basis when the markets open on February 24, 2025, under the existing trading symbol "HWH." The reverse stock split is primarily intended to bring the Company into compliance with the minimum bid price requirements for maintaining its listing on the Nasdaq Capital Market. The new CUSIP number following the reverse stock split will be 448

    2/20/25 8:50:00 AM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering

    BETHESDA, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the "Offering") with aggregate gross proceeds to the Company of $1,764,900, prior to deducting fees and other expenses payable by the Company. The Offering consisted of 3,412,500 shares of common stock and 1,000,000 pre-funded warrants to purchase 1,000,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold at a purchase price of $0.40 per share (or $0.3999 per pre-funded warrant after reducing $0.0001 attributable to the exercise price of the pre-funded

    1/7/25 11:18:56 AM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    HWH International Inc. Announces Closing of Approximately $1.76 Million Public Offering at $0.40 per Share

    BETHESDA, MD, Jan. 06, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the "Offering") with aggregate gross proceeds to the Company of $1,764,875, prior to deducting fees and other expenses payable by the Company. The Offering consisted of 3,125,000 shares of common stock and 1,250,000 pre-funded warrants to purchase 1,250,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold at a purchase price of $0.40 per share (or $0.3999 per pre-funded warrant after reducing $0.0001 attributable to the exercise price of the pre-funded w

    1/6/25 4:20:00 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Chan Heng Fai Ambrose bought $585,000 worth of shares (1,300,000 units at $0.45) (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    12/26/24 5:15:05 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Director Chan Heng Fai Ambrose bought $3,000,000 worth of shares (4,411,764 units at $0.68) (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    11/26/24 7:12:12 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Chan Heng Fai Ambrose bought $3,801,758 worth of shares (6,034,537 units at $0.63) (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    9/26/24 9:39:51 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Large owner Chan Heng Fai Ambrose

    4 - HWH International Inc. (0001897245) (Reporting)

    1/20/26 4:59:26 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Chan Heng Fai Ambrose was granted 1,000,000 shares, increasing direct ownership by 38,462% to 1,002,600 units (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    12/1/25 5:10:23 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    SEC Form 4 filed by Large owner Chan Heng Fai Ambrose

    4 - HWH International Inc. (0001897245) (Reporting)

    10/7/25 5:00:04 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    Financials

    Live finance-specific insights

    View All

    HWH International Inc. Acquires Café in South Korea, Unveiling Second Hapi Cafe Outlet

    Bethesda, MD, Feb. 26, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. ("HWH") (NASDAQ:HWH) proudly announces the acquisition of a café in Seocho-gu, South Korea, marking the launch of its second Hapi Cafe outlet in South Korea. HWH is delighted to reveal its latest acquisition of a café nestled in the heart of Seocho-gu, South Korea. This strategic move signifies HWH's dedication to providing unique and welcoming spaces where people can gather to savor food, coffee, and experiences. These cafes are a significant driver of our Health, Wealth, and Happiness vision to offer delicious and nutritious food and beverages to our customers and provide a platform where we can roll out lifestyle pr

    2/26/24 4:15:00 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by HWH International Inc.

    SC 13D/A - HWH International Inc. (0001897245) (Subject)

    11/26/24 7:34:11 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13D/A filed by HWH International Inc.

    SC 13D/A - HWH International Inc. (0001897245) (Subject)

    11/22/24 5:00:10 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by HWH International Inc.

    SC 13G/A - HWH International Inc. (0001897245) (Subject)

    11/14/24 12:40:52 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care